September 2026
The cell therapy market size reached USD 9.13 billion in 2026, with leading cell therapy market companies including cell therapy , Cells for Cells, Celgene Corporation.
September 2026
The global cell encapsulation technology market is growing as regenerative medicine and cell therapies adopt protective encapsulation techniques.
September 2026
The global cell and gene therapy quality control and analytics market is expanding with growing demand for robust testing, validation, and compliance in advanced therapies.
September 2026
The cell and tissue preservation market reached USD 5.77 billion in 2026, featuring leading cell and tissue preservation companies such as lonza, chart industries, biolife solutions, thermos fisher scientific.
September 2026
The cellular vehicle-to-everything (C-V2X) market reached USD 2.22 billion in 2026, with prominent companies such as Qualcomm Technologies Inc., Huawei Technologies Co., Ltd., Intel Corporation leading the cellular vehicle-to-everything (C-V2X) market.
September 2026
The cell-free protein expression market size is expected to increase from USD 313.88 million 2026 and is expected to hit around USD 585.10 million by 2034 with a CAGR of 8.07%.
September 2026
The cell penetrating peptide market size was estimated at USD 2.88 billion in 2026 and is expected to hit around USD 9.95 billion by 2035, growing at a CAGR of 14.9%.
September 2026
The global cell lysis & disruption market size was valued at USD 6.78 billion in 2026 and is expected to hit around USD 14.56 billion by 2035, growing at a CAGR of 8.88% from 2026 to 2035.
September 2026
The global cell cryopreservation market size is valued at USD 1,818.3 million in 2026 and is projected to hit around USD 5,028.90 million by 2035 with a CAGR of 11.85%.
September 2026
The cell and gene therapy manufacturing market size is predicted to hit around USD 122.86 billion by 2034 from USD 18.06 billion in 2026, with a CAGR of 26.62%.
September 2026
The global cell surface marker detection market size is estimated to hit around USD 13.76 billion by 2035, increasing from USD 6.68 billion in 2026, with a CAGR of 8.37%.
September 2026
The global cell and gene therapy bioanalytical testing services market size is expected to hit around USD 1,113.86 million by 2034 from USD 632.03 million in 2026, with a CAGR of 7.34%.
September 2026
The global cell analysis market size is estimated to hit around USD 84.01 billion by 2034 increasing from USD 39.74 billion in 2026, with a CAGR of 9.81%.
August 2026
The cell culture media market was valued at USD 8.59 billion in 2026, with leading companies including Merck KGaA, FUJIFILM Irvine Scientific, Inc., CYTIVA (Danaher).
August 2026
The global cell and gene therapy clinical trials market size is projected to hit around USD 54.29 billion by 2034 from USD 13.32 billion in 2024 with a CAGR of 15.09%
July 2026
The cell and gene therapy market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
July 2026
The global cell dissociation market size was reached at USD 710 million in 2025 and is expected to hit around USD 2,433 million by 2035 with a CAGR of 13.11%.
July 2026
The cell and gene therapy patient access and reimbursement market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries..
June 2026
The global cellulose-reinforced hydrogels market size is evaluated at USD 1.44 billion in 2025 and is predicted to hit around USD 2.78 billion by 2035, growing at a CAGR of 6.80%.
June 2026
The global cell therapy manufacturing market size was valued at USD 5.55 billion in 2025 and is projected to hit around USD 21.02 billion by 2035 with a CAGR of 14.24%.
May 2026
The cellulose fiber market size was valued at USD 45.82 billion in 2025 and is projected to attain around USD 72.94 billion by 2035, with a CAGR of 4.76%.
May 2026
The cell expansion market size was evaluated at USD 22.14 billion in 2025 and is predicted to surpass around USD 67.46 billion by 2035, growing at a CAGR of 11.79%.
May 2026
The cell separation market size was exhibited at USD 14.15 billion in 2025 and is estimated to hit around USD 47.14 billion by 2035, growing at a solid CAGR of 12.79%.
April 2026
The cellular health screening market size was valued at USD 3.73 billion in 2025 and is expected to hit around USD 7.98 billion by 2035 at a CAGR of 7.90%.
April 2026
The global cell and gene therapy market size was calculated at USD 8.94 billion in 2025 and is projected to surpass around USD 47.18 billion by 2035 with a solid CAGR of 18.1%.
March 2026
The global cell culture market size is calculated at USD 32.23 billion in 2025 and is projected to hit around USD 83.96 billion by 2035 with a CAGR of 10.05%.
February 2026
The global cell line development market size surpassed USD 6.39 billion in 2025 and is projected to reach around USD 15.85 billion by 2035 with a notable CAGR of 9.51%.
February 2026
The global cell-based assays market size is projected to hit around USD 44.23 billion by 2035 from USD 19.78 billion in 2025 with a CAGR of 8.38%.
February 2026
The global cell counting market size was exhibited at USD 11.09 billion in 2025 and is projected to surpass around USD 24.08 billion by 2035, with a notable CAGR of 8.06%.
February 2026
The global cell cycle inhibitors market size was evaluated at USD 5.72 billion in 2025 and is predicted to hit around USD 11.50 billion by 2035, growing at a CAGR of 7.23%.